FemTech Sector to Alleviate Growing Void Left by NHS Fertility Cuts
Anita Riotta
Investor Insights
10:14, 30th November 2018

Efforts by NHS Clinical Commissioning Groups (CCGs) to fill an approximately £12m budget hole have resulted in large cuts to the fertility options available to women across the UK. 

Under regular National Institute for Health and Care (NICE) rules, women under 40 in the UK should be offered three free cycles of in-vitro fertilisation (IVF) if they have been trying to become pregnant for two years or have not gotten pregnant after 12 rounds of artificial insemination.

However, faced with this budget deficit, health chiefs in Rochdale, Middletown, Heywood, and Greater Manchester are considering cutting three cycles down to one or placing stricter requirements. For instance, in 12 areas in England women over the age of 34 are being automatically refused IVF treatments. 

With this news and the knowledge that private IVF treatments cost between £3,000 and £5,000 per cycle, many women are faced with mounting pressure to capitalise on each attempt to become pregnant. 

This already difficult task becomes all the more tenuous when considering that, in the UK, nearly two-thirds of women don’t know how long their fertile window lasts. Yet, aid is being provided by the burgeoning fertility industry, worth more than £320 million in the UK alone.

The so-called ‘Femtech’ sector, technology, applications, and gadgets focused on female well-being, is generating products aimed at providing women with more in-depth and real-time information about their fertility. 

Today, more than a quarter of women have used pregnancy apps and other technology aids to help them conceive, and 10% of women have spent more than £200 to increase their chances of getting pregnant.

Concepta’s myLotus, for example, detects the actual concentration of hormones in a woman’s urine sample allowing “detailed analysis into issues with ovulation and fertility that aren’t available with traditional ovulation tests on the market.”

The company is looking beyond the UK as well, looking to rollout throughout Europe and then distribute in China where market demands have already been determined. The annual revenue potential of the infertility market in China and Europe is around £600 million.

By 2025, the ‘femtech’ sector is estimated to be worth £39 billion. These female well-being technologies and companies such as Concepta are creating new opportunities in the tech world that should not be overlooked.

For more news and updates on Concepta: FOLLOW


Recent Articles
  • Cobra Resources IPO Insights
    13th Dec 2018

    As part of the listing, the company raised £523,500 before expenses through a share placing. It has also issued warrants that if they were all exercised would raise a further £1.3 million.

  • Hummingbird Resources (HUM) Europa Metals (EUZ) Block Energy (BLOE) and Chris Bailey on (SDRY) (BON) (TCG) (PZC)
    13th Dec 2018

    On today's podcast: Hummingbird Resources discuss 2019 guidance and its drill results from the 2018 exploration campaign. Europa Metals talks about their Scoping Study. Block Energy discusses the advanced technology they have secured for their multi-well programme in Georgia. Chris Bailey covers: Superdry, Bonmarche, Thomas Cook Group, Tui Group & PZ Cussons.

  • See Today's AIM Risers Featuring Thor Mining Upgrading its Mineral Resource
    13th Dec 2018

    See Today's AIM Risers Featuring Thor Mining Upgrading its Mineral Resource.

  • SP Angel . Morning View . Metals rise as tariff trade tensions ease
    13th Dec 2018

    SP Angel morning look at commodities featuring: Bacanora Lithium (BCN LN) – Blackrock cuts stake Erris Resources (ERIS LN) – Exploration update Hummingbird Resources (HUM LN) – Progress report on exploration drilling Savannah Resources (SAV LN) – High-quality saleable by-product from Mino do Barroso lithium project Thor Mining (THR LN) – Mineral resource update at Pilot Mountain

  • Hummingbird Resources Releases High-Grade Gold Mine Drill Results
    Anita Riotta
    Company News
    13th Dec 2018

    Hummingbird Resources, an African gold producer, released the second set of drill results from their exploration campaign in Mali. The company aims to transform its resources into reserves and eventually extend the life of their Yanfolila Gold Mine.

  • US FDA Confirms Target Date For Completion Of Feraccru Review
    13th Dec 2018

    Shield Therapeutics (STX) announced today that the US Food and Drug Administration has confirmed that the target date for completion of the New Drug Application review of Feraccru is 27 July 2019, under the terms of the Prescription Drug User Fee Act.

  • Morning Financial Press Round-Up
    13th Dec 2018

    Sainsbury’s hit by Asda deal doubts, Dixons £460m loss fuels fears of High St bloodbath but new boss insists turnaround plan is still on track

  • 5 Things You Need To Know, Today, on Thursday 13th December 2018
    13th Dec 2018

    Five financial stories, trending today in a 70 second podcast, including: Theresa May is heading to Brussels for an EU summit, less than 24 hours after surviving a vote of confidence. The prime minister is seeking legally binding pledges from EU leaders on the Irish backstop - a key obstacle for MPs who oppose her Brexit deal.

  • IPO Insights with Golden Saint Technologies
    12th Dec 2018

    GST is an innovative global technology and investment company. Its main business is its profitable, 28-year old, Singapore - based subsidiary - EMS Wiring - that provides integrated Information and Communication Technology (ICT) solutions worldwide.

  • Tekcapital (TEK), Reabold Resources (RBD) and Mining Analyst John Meyer
    12th Dec 2018

    On today's podcast: Dr. Clifford Gross, Chairman at Tekcapital give an update on their portfolio companies. Sachin Oza, Co-Chief Executive Officer of Reabold Resources provides an update on their operations. John Meyer covers BHP Billiton Rio Tinto, Anglo-American Mining, Mkango Resources, Anglo-Asian Mining & Bluejay Mining.